Norton Hospitals’ postgraduate year two (PGY2) oncology pharmacy residency program builds upon Doctor of Pharmacy (Pharm.D.) education and postgraduate year one (PGY1) pharmacy residency training to develop clinical pharmacists in the oncology area of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 oncology pharmacy residency are eligible for board certification in oncology. The resident is prepared for clinical pharmacist oncology specialist positions such as an advanced patient care practitioner, academia, research and other specialized positions involving hazardous medications.
Each resident’s schedule is shaped to allow for progressive development of knowledge and skills and to best prepare them for the next step of their career. Rotational and longitudinal experiences encompass a multitude of oncologic disease states, such as breast, gastrointestinal, lung and central nervous system malignancies, and many more. Hematologic disease states include, but are not limited to, adult leukemias, lymphomas, multiple myeloma, bone marrow transplant, and CAR T-cell therapy. Additional learning experiences include pediatric malignancies, investigational drug services, medication safety and quality, and practice management. Residents will complete a longitudinal research project. Opportunities exist to mentor and educate students and PGY1 residents through both didactic and practice-based teaching.
All pharmacy residents are eligible for Norton Healthcare’s full employee benefits. Each PGY2 resident is salaried and receives a stipend of $56,100 plus benefits. A full benefits guide can be found here. The position requires a commitment of one calendar year. The estimated start date for PGY2 is late June/early July.
Benefits at a glance
Applications for the Norton Hospitals PGY2 Oncology Pharmacy Residency Program must be accessed through the Pharmacy Online Residency Centralized Application Service (PhORCAS). There are no additional application materials required beyond PhORCAS requirements. All candidates will be notified regarding selection for an on-site or virtual interview. Interviews will occur in January and/or February.
The candidate must have completed an American Society of Health-System Pharmacists (ASHP)-accredited PGY1 program or one in the accreditation process. A copy of the PGY1 residency certificate and Kentucky pharmacist licensure must be provided to the residency program director on or before the first day of starting the PGY2 residency program.
To apply to this residency program, go to the PhORCAS applicant webpage. Refer to PhORCAS for the application deadline.
Number of positions: One Start date: Late June/early July
Requirements:
Required Experiences:
• Breast cancer, gynecologic malignancies and sarcoma • Gastrointestinal cancers • Genitourinary cancers, head and neck cancers • Hematology: Leukemias, infection prevention • Hematology: Lymphoma, Cellular Therapy • Lung cancer, central nervous system malignancies, melanoma • Orientation, supportive care • Outpatient hematology • Pediatric malignancies/pediatric bone marrow transplant
Required Longitudinal Experiences:
• Investigational drug services • Medication safety and quality • Practice management/leadership • Research/PGY2 residency project • Staffing
Elective Experiences:
• Specialty pharmacy • Transitions from training to practice
Jeffrey Bahng , Pharm.D., BCPS
Jeffrey received his Doctor of Pharmacy degree from Rutgers University Ernest Mario School of Pharmacy, Piscataway, New Jersey, in 2008. He is a recipient of the Air Force Health Professions Scholarship Program and served in the US Air Force with the rank of captain at Little Rock Air Force Base in Arkansas as chief of outpatient pharmacy. He was the 19th Medical Support Squadron Company Grade Officer of the Year in 2009 and was recognized for the Air Force Pharmacy of the Year in 2010. Following his military service, Jeffrey completed a postgraduate residency (PGY1) at Norton Healthcare in 2012. He then joined the organization as a clinical staff pharmacist at Norton Hospital, serving as an advanced pharmacy practice experiences preceptor for University of Kentucky and residency preceptor for internal medicine. In 2019, Jeffrey joined Norton Cancer Institute and then transitioned to the role of clinical research pharmacist in 2023. Jeffrey is board certified in pharmacotherapy and has completed a certificate in biostatistics from the University of Louisville School of Public Health & Information Sciences. He is currently pursuing his Master of Science in biostatistics and has an interest in study design, applied statistics, drug development, clinical trials and oncology research. Jeff serves as the primary preceptor for the investigational drug services rotation.
Kelly Bailey, Pharm.D., BCOP
Kelly is a clinical pharmacy specialist in oncology at Norton Cancer Institute – Downtown. She received her Doctor of Pharmacy degree from Butler University, Indianapolis, Indiana. She completed a PGY1 pharmacy practice residency at Norton Healthcare and a PGY2 oncology pharmacy practice residency at Northwestern Memorial Hospital in Chicago, Illinois. After residency, Kelly worked as a clinical pharmacy specialist in inpatient oncology at the University of Cincinnati Medical Center in Ohio. In 2013, Kelly joined Norton Healthcare as an Epic Beacon analyst and holds Epic certifications in Beacon and Willow. In 2017, Kelly joined Norton Cancer Institute as a clinical pharmacy specialist and serves as a preceptor to PGY1 and PGY2 residents.
Becky Champion, Pharm.D., BCOP
Rebecca is a board-certified oncology pharmacist at Norton Cancer Institute. She received her Doctor of Pharmacy degree at the University of Kentucky College of Pharmacy, Lexington, and has been with Norton Healthcare for 21 years. She currently serves as the clinical manager at Norton Cancer Institute, where her responsibilities include Epic Beacon protocol management; pharmacy and therapeutics (P&T) review of new medications; and oversight of clinical pharmacy services. Becky is an active member of the Hematology/Oncology Pharmacy Association and the American Society of Hematology.
Stacy Epstein, Pharm.D., BCOP
Stacy is a clinical pharmacist specialist in oncology at Norton Cancer Institute. She received a bachelor’s degree in biochemistry and molecular biology from Centre College in Danville, Kentucky, and her doctorate in pharmacy from the University of Kentucky College of Pharmacy. She completed a PGY1 pharmacy practice residency and a PGY2 hematology/oncology pharmacy residency at the University of North Carolina Medical Center in Chapel Hill. Stacy joined Norton Cancer Institute 2016 and serves as a preceptor to PGY1 and PGY2 pharmacy residents.
Rebecca Juhl, Pharm.D., BCOP
Rebecca is a clinical pharmacy specialist in oncology at Norton Cancer Institute – St. Matthews. She received a bachelor’s degree in chemistry from Centre College, Danville, Kentucky, and a doctorate in pharmacy from the University of Kentucky College of Pharmacy. She completed a PGY1 pharmacy residency at The Ohio State University Wexner Medical Center and a PGY2 oncology pharmacy residency at The Ohio State University Comprehensive Cancer Center – James Cancer Hospital in Columbus. Rebecca serves as a preceptor to PGY1 and PGY2 Norton Healthcare pharmacy residents.
Clark Moehlenbrock, Pharm.D.
Clark is a clinical pharmacy specialist in oncology at Norton Cancer Institute – Downtown. He received his Doctor of Pharmacy degree from the University of Oklahoma, Oklahoma City. He completed a PGY1 pharmacy practice residency and a PGY2 oncology pharmacy practice residency at Norton Healthcare. After residency, Clark worked as a clinical pharmacy specialist at a cancer care center in Elizabethtown, Kentucky. In 2024, Clark joined Norton Cancer Institute as a clinical pharmacy specialist and serves as a preceptor to PGY1 and PGY2 residents.
LeeAnn Morris, Pharm.D, BCOP
LeeAnn is a clinical pharmacist specialist in oncology at Norton Cancer Institute, where she is the float specialist and travels to all five of the institute’s clinics, with her primary clinic being in Jeffersonville, Indiana. She received a doctorate in pharmacy from the University of Kentucky College of Pharmacy. She completed a PGY1 pharmacy practice residency at UC Health Medical Center in Cincinnati, Ohio, and a PGY2 hematology oncology pharmacy practice residency at The Ohio State University Comprehensive Cancer Center – James Cancer Hospital in Columbus. LeeAnn joined Norton Cancer Institute in 2019 and serves as a preceptor to PGY1 and PGY2 pharmacy residents.
Kaley Pagan, Pharm.D, BCOP
Kaley is a clinical pharmacist specialist in oncology at Norton Cancer Institute and is a former PGY2 resident of the Norton Hospitals Oncology Pharmacy Residency Program. She received a doctorate in pharmacy from the University of Florida, Gainesville, and completed a PGY1 pharmacy practice residency at St. Joseph East hospital in Lexington, Kentucky. Kaley joined Norton Cancer Institute in 2022 after completion of her PGY2 oncology residency and serves as a preceptor to PGY1 and PGY2 pharmacy residents.
Kami Redecker, Pharm.D., BCOP, BCPS
Kami is a clinical pharmacist specialist at Norton Cancer Institute as well as the director of the PGY2 Oncology Pharmacy Residency Program. She received a Bachelor of Science degree from Morehead State University in Morehead, Kentucky, and her doctorate in pharmacy from Shenandoah University’s Bernard J. Dunn School of Pharmacy in Winchester, Virginia. She has worked at Norton Healthcare for 17 years and is board certified in pharmacotherapy and oncology. She serves as a preceptor to PGY1 and PGY2 pharmacy residents as well as a preceptor to fourth-year pharmacy students from the University of Kentucky.
Alex Schickli, Pharm.D., BCOP
Alex is a clinical pharmacist specialist at Norton Cancer Institute and specializes in oral anticancer medications. She received a doctorate in pharmacy from the University of Kentucky College of Pharmacy. She completed a PGY1 pharmacy practice residency at Saint Joseph Hospital in Lexington, Kentucky, and a PGY2 hematology/oncology pharmacy practice residency at The Ohio State University Comprehensive Cancer Center at the James Cancer Hospital in Columbus, Ohio.
For additional information, contact:
Kami Redecker, Pharm.D., BCOP, BCPSClinical Pharmacist Specialist
PGY2 Oncology Pharmacy Residency Program Director4955 Norton Healthcare Blvd.
Louisville, KY 40241
Phone: (502) 394-6350, ext. 19843Email: kami.redecker@nortonhealthcare.org
Select an appointment date and time from available spots listed below.